Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026)

Ufp Technologies (UFPT) posted Cash from Financing Activities of -$1.6 million for Q1 2026, up 85.12% on a QoQ basis from -$10.9 million in Q4 2025, and up 84.87% year-over-year from -$875767.9 in Q1 2025.

Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Ufp Technologies' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 84.87% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.1 million (down 133.98% YoY) and the FY2025 annual result came in at -$58.2 million, down 138.16% from the prior year.
  • Cash from Financing Activities was -$1.6 million for Q1 2026 at Ufp Technologies, up from -$10.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $176.8 million in Q3 2024 and bottomed at -$28.9 million in Q3 2022.
  • A 5-year average of $2.2 million and a median of -$10.7 million in 2025 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 3127.1% in 2022, while the deepest fall reached 721350.0% in 2022.
  • Ufp Technologies' Cash from Financing Activities stood at -$20.7 million in 2022, then soared by 45.74% to -$11.2 million in 2023, then slumped by 102.04% to -$22.7 million in 2024, then soared by 52.09% to -$10.9 million in 2025, then jumped by 85.12% to -$1.6 million in 2026.
  • Business Quant data shows UFPT's Cash from Financing Activities at -$1.6 million in Q1 2026, -$10.9 million in Q4 2025, and -$17.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Ufp Technologies 1.82 Bn 1.80 Bn 44.36 Mn -1.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.62 Mn
Mar 31, 2026 -1.62 Mn
Dec 31, 2025 -10.88 Mn
Dec 31, 2025 -10.88 Mn
Sep 30, 2025 -17.49 Mn
Sep 30, 2025 -17.49 Mn
Jun 30, 2025 -19.08 Mn
Jun 30, 2025 -19.08 Mn
Mar 31, 2025 -10.70 Mn
Mar 31, 2025 -10.70 Mn
Dec 31, 2024 -22.72 Mn
Dec 31, 2024 -22.72 Mn
Sep 30, 2024 176.78 Mn
Sep 30, 2024 176.78 Mn
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 -2.72 Mn
Mar 31, 2024 -2.72 Mn
Dec 31, 2023 -11.24 Mn
Dec 31, 2023 -11.24 Mn